Tower Research Capital LLC (Trc) Gracell Biotechnologies Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$2.43 - $10.04 $70,394 - $290,848	-28,969 Reduced 84.13%	5,465 $54,000
Q3 2023 Nov 14, 2023	BUY	$2.83 - $4.9 $66,270 - $114,743	23,417 Added 212.55%	34,434 $99,000
Q2 2023 Aug 14, 2023	BUY	$1.45 - $6.07 $4,860 - $20,346	3,352 Added 43.73%	11,017 $41,000
Q1 2023 May 09, 2023	SELL	$1.8 - $2.5 $10,548 - $14,650	-5,860 Reduced 43.33%	7,665 $14,000
Q4 2022 Feb 10, 2023	BUY	$2.08 - $3.96 $10,749 - $20,465	5,168 Added 61.84%	13,525 $31,000

Q3 2022 Nov 10, 2022	BUY	$2.08 - $5.15 $16,122 - $39,917	7,751 Added 1279.04%	8,357 $27,000
Q2 2022 Aug 15, 2022	SELL	$1.95 - $5.5 $3,018 - $8,514	-1,548 Reduced 71.87%	606 $3,000
Q1 2022 May 12, 2022	SELL	$1.83 - $5.52 $364 - $1,098	-199 Reduced 8.46%	2,154 $5,000
Q4 2021 Feb 14, 2022	BUY	$5.65 - $14.9 $13,294 - $35,059	2,353 New	2,353 $14,000

75.1K

Ticker GRCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,674,096
Description
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the tre...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.